n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with Meningioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baerwald, R; Cordes, M; Gerlach, L; Maier-Hauff, K | 1 |
| Dillehay, GL; Ghobrial, MW; Karesh, SM; McVeigh, MC; Merchut, MP | 1 |
2 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Meningioma
| Article | Year |
|---|---|
Cerebral blood flow measurements with HMPAO- and HIPDM-SPECT in brain tumors: basic rCBF studies.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Cerebrovascular Circulation; Female; Glioma; Humans; Iodobenzenes; Lymphoma; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Organotechnetium Compounds; Oximes; Regional Blood Flow; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1989 |
Intracranial tumors: unexpected uptake of I-123 HIPDM.
Topics: Astrocytoma; Brain Neoplasms; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Meningeal Neoplasms; Meningioma; Middle Aged; Radionuclide Imaging | 1986 |